Diabetes study helps families sleep easier

June 20, 2014 by Paul Mayne, University of Western Ontario

Two Western professors hope their clinical trial will soon lead to eliminating overnight dangers for children with Type 1 diabetes.

Schulich School of Medical & Dentistry professors Drs. Cheril Clarson and Irene Hramiak, both Lawson Health Research Institute scientists, are leading the only Canadian study evaluating a tool for preventing low blood sugars in patients while they sleep.

Low , or hypoglycemia, is a condition that can lead to coma, seizures or death for individuals with diabetes. More than half of these episodes occur during sleep hours and, in children, the rate is even higher, with 75 per cent of hypoglycemic seizures occurring overnight.

And the number of children being diagnosed each year with Type 1 diabetes – 1 in 500 – has doubled over the last few decades, Clarson said.

"If this system reduces nighttime hypoglycemia, and improves quality of life for children with diabetes and their families, it will also help patients to achieve better diabetic control and reduce the risk of long-term complications from diabetes," she added.

Currently in use, pumps help to reduce the risk of hypoglycemia by administering constant levels of insulin. However, they rely on the user to monitor their blood sugar levels and adjust as necessary – a manual task that cannot be performed while sleeping.

In the trial, Clarson and Hramiak are testing a tool that mimics the pancreas to reduce the rate of nocturnal hypoglycemia. It combines a pump to deliver insulin, a continuous glucose-monitoring system to measure blood sugars in the patient every five minutes and a computer algorithm that predicts when each individual is at risk for hypoglycemia.

Clarson said the idea is for the tool is to avoid low blood sugar by turning the insulin pump off when it predicts high risk for low-blood sugar, and then back on when the risk has been resolved.

"This study combines two technologies that have been used for quite a few years," Clarson said. "But there is no commercially available system that is fully functional, or closed loop, which is what a pancreas would be doing. This is where we're heading.

"This is a step forward because it is predicting low blood sugar, and it is much better to prevent than to have severe symptoms that often occur when the blood sugar shoots up. It's much better to prevent that from happening."

A previous trial, led by Hramiak, studied 45 adult patients age 15-45 years and yielded positive results, helping participants keep blood sugar levels stable while patients slept.

"It's a simple solution to a major problem for individuals wearing an insulin pump," Hramiak said. "We have tested the system in adults and now are testing it in a group of 20 children ages 3-15. This system could potentially prevent overnight and is a first step to developing a system that functions like a native pancreas."

Explore further: Modified iPhone shows promise against type 1 diabetes

Related Stories

Modified iPhone shows promise against type 1 diabetes

June 16, 2014
A device that uses a modified iPhone to help regulate the blood sugar of people with type 1 diabetes appears to work better than an insulin pump, researchers say.

For slumbering diabetics, a way to detect low blood sugar and stop insulin delivery

May 7, 2014
New research could soon make it easier for people with type-1 diabetes to get a safe night's sleep, says a Stanford University School of Medicine scientist who led the study.

Low blood sugar may affect heartbeat in people with diabetes

April 22, 2014
(HealthDay)—Low blood sugar levels—known as hypoglycemia—in people with diabetes may cause potentially dangerous changes in heart rate, according to a small new study.

Advances in predictive hypoglycemia-minimizing technology from Animas-JDRF collaboration

June 16, 2014
Animas Corporation today shared encouraging results from its predictive hypoglycemia-minimizing algorithm in development. Data from a clinical feasibility study demonstrated that the algorithm was capable of helping maintain ...

Bionic pancreas outperforms insulin pump in adults, youth

June 16, 2014
People with type 1 diabetes who used a bionic pancreas instead of manually monitoring glucose using fingerstick tests and delivering insulin using a pump were more likely to have blood glucose levels consistently within the ...

Diabetes Association sets new A1C target for children with type 1 diabetes

June 16, 2014
According to a new position statement released at the Association's 74th Scientific Sessions, the American Diabetes Association is lowering its target recommendation for blood glucose levels for children with type 1 diabetes, ...

Recommended for you

Women who have gestational diabetes in pregnancy are at higher risk of future health issues

January 16, 2018
Women who have gestational diabetes mellitus (GDM) during pregnancy have a higher than usual risk of developing type 2 diabetes, hypertension, and ischemic heart disease in the future, according to new research led by the ...

Diabetes gene found that causes low and high blood sugar levels in the same family

January 15, 2018
A study of families with rare blood sugar conditions has revealed a new gene thought to be critical in the regulation of insulin, the key hormone in diabetes.

Discovery could lead to new therapies for diabetics

January 12, 2018
New research by MDI Biological Laboratory scientist Sandra Rieger, Ph.D., and her team has demonstrated that an enzyme she had previously identified as playing a role in peripheral neuropathy induced by cancer chemotherapy ...

Enzyme shown to regulate inflammation and metabolism in fat tissue

January 11, 2018
The human body has two primary kinds of fat—white fat, which stores excess calories and is associated with obesity, and brown fat, which burns calories in order to produce heat and has garnered interest as a potential means ...

Big strides made in diabetes care

January 5, 2018
(HealthDay)—This past year was a busy, productive one for diabetes research and care.

Gene therapy restores normal blood glucose levels in mice with type 1 diabetes

January 4, 2018
Type 1 diabetes is a chronic disease in which the immune system attacks and destroys insulin-producing beta cells in the pancreas, resulting in high blood levels of glucose. A study published January 4th in Cell Stem Cell ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.